Sign In
Buy IXJ
$92.28
+0.360 (+0.392%)
At Close: Jun 03, 2026
U.S. Health Care Depth or Global Industry Reach? VHT vs. IXJ
03:08pm, Monday, 01'st Jun 2026
The Vanguard Health Care ETF (VHT) and the iShares Global Healthcare ETF (IXJ) both target health care stocks, but they are tailored to different investor needs. One emphasizes broad, low-cost U.S. ex
GLP-1 Drugs Powered IHE's Big Year. IXJ Is Playing a Longer Game.
11:17am, Wednesday, 27'th May 2026
A closer look at portfolio makeup, yield, and risk reveals what sets these two iShares healthcare funds apart for investors seeking sector exposure.
PPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare Ecosystem
09:12am, Wednesday, 27'th May 2026
VanEck Pharmaceutical ETF offers a concentrated portfolio focused exclusively on drug manufacturers. iShares Global Healthcare ETF provides broader diversification across more than 100 companies in th
ASX 200 index on edge as Australian bond yields fall after inflation cools
10:35pm, Tuesday, 26'th May 2026
The ASX 200 Index remained in a tight range while Australian bond yields fell after the latest consumer inflation report. It was trading at A$8,660, a few points below this week's high of A$8,715.
Leo Wealth LLC Has $14.30 Million Stock Holdings in iShares Global Healthcare ETF $IXJ
06:58am, Monday, 06'th Apr 2026
Leo Wealth LLC grew its stake in shares of iShares Global Healthcare ETF (NYSEARCA:IXJ) by 59.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned
IXJ: Healthcare Sector Dashboard For February
10:00am, Wednesday, 18'th Feb 2026
While the broad market is overpriced, value still exists in the healthcare sector, especially in healthcare providers and healthcare equipment. iShares Global Healthcare ETF offers global healthcare e
Betting on a Boom: 3 Healthcare ETFs for 2026 and Beyond
12:40pm, Friday, 09'th Jan 2026
After a late-2025 rebound eased policy fears, healthcare ETFs like IXJ are gaining attention as investors position for a sector comeback in 2026.
iShares Global Healthcare ETF (NYSEARCA:IXJ) Hits New 52-Week High – Here’s Why
01:18am, Sunday, 28'th Dec 2025
Shares of iShares Global Healthcare ETF (NYSEARCA:IXJ - Get Free Report) hit a new 52-week high on Friday. The company traded as high as $99.48 and last traded at $98.0080, with a volume of 122 shares
Osaic Holdings Inc. Has $2.79 Million Stake in iShares Global Healthcare ETF $IXJ
05:13am, Saturday, 27'th Dec 2025
Osaic Holdings Inc. boosted its position in shares of iShares Global Healthcare ETF (NYSEARCA:IXJ) by 27.7% during the undefined quarter, according to the company in its most recent filing with the SE
IXJ: Healthcare Sector Dashboard For October
10:19am, Monday, 20'th Oct 2025
Healthcare providers and pharmaceuticals/biotechnology subsectors are undervalued versus 11-year averages, with pharma/biotech also showing strong quality metrics. iShares Global Healthcare ETF (IXJ):
If the AI Bubble Bursts, Here Are Some Defensive ETFs to Consider
12:00pm, Thursday, 09'th Oct 2025
As AI-fueled gains spark bubble warnings, investors are eyeing defensive ETFs in consumer staples, utilities and healthcare for safety.
Unlocking Cures: How AI is Reshaping Cancer Research & Healthcare ETFs?
08:31am, Wednesday, 01'st Oct 2025
AI's growing role in cancer research, and a new federal push for pediatric oncology, are powering gains in key healthcare ETFs.
On IXJ, A Contradiction Has Emerged That Is Too Big To Be Ignored
12:17pm, Thursday, 14'th Aug 2025
Tough moment for healthcare: low momentum, high volatility, and downgraded EPS. It is evident when looking at the IXJ ETF, focused on global healthcare: 70% US, 30% international. But relative valuati
IXJ: A Bet On Global Healthcare Recovery
01:33am, Wednesday, 30'th Jul 2025
IXJ offers global healthcare exposure, capturing demographic shifts and innovation trends beyond U.S.-centric ETFs for a more balanced risk/reward profile. The fund's heavy allocation to pharmaceutica
IXJ: Healthcare Sector Dashboard For May
11:50am, Wednesday, 14'th May 2025
This article provides a top-down analysis of the healthcare sector using value, quality, and momentum metrics. Healthcare providers and pharmaceuticals/biotechnology are the most compelling subsectors
